+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Digital Pathology Systems - Global Market Trajectory & Analytics

  • ID: 2531223
  • Report
  • February 2022
  • Region: Global
  • 620 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • 3DHISTECH Ltd.
  • Corista LLC
  • Hamamatsu Photonics K.K.
  • Indica Labs
  • KANTERON SYSTEMS S.L.U
  • Olympus Corporation

Global Digital Pathology Systems Market to Reach $1.2 Billion by 2026


In recent years, digital pathology has been emerging as one of the most promising technologies in clinical pathology and holds tremendous potential in replacing the traditional microscope-based diagnosis in the near future. Recent advancements in digital photography and slide scanning, and the declining prices of digital cameras have been revolutionizing conventional methods for the documentation of pathology findings, and the achievement of collaborative slide review and image analysis. Considerable skill is required to process and stain fluids and tissues for investigation. Digital pathology enables pathologists to collaborate on slide review across laboratories as well as transmit images to other experts for their first readings or second opinions. Digital pathology systems continue to attract attention in various end-use applications such as diagnostic tests, drug discovery & development, education & training, and academic research in human pathology, veterinary pathology, oral pathology and forensic pathology. Within the diagnostics space, digital pathology systems continue gain traction in medical microscopy, blood analysis, biopsy and dissection among others in the diagnosis of physiological disorders, and organic and infectious diseases.

Amid the COVID-19 crisis, the global market for Digital Pathology Systems estimated at US$573.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2026, growing at a CAGR of 13.9% over the analysis period. Device, one of the segments analyzed in the report, is projected to grow at a 13.8% CAGR to reach US$753.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 14.6% CAGR for the next 7-year period. This segment currently accounts for a 29.2% share of the global Digital Pathology Systems market.



The U.S. Market is Estimated at $295.3 Million in 2021, While China is Forecast to Reach $102.9 Million by 2026


The Digital Pathology Systems market in the U.S. is estimated at US$295.3 Million in the year 2021. The country currently accounts for a 42.12% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$102.9 Million in the year 2026 trailing a CAGR of 15.1% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.9% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR while Rest of European market (as defined in the study) will reach US$114.2 Million by the close of the analysis period.

Factors like COVID-19 along with rising cases of cancer and associated need to diagnose patient biopsies are providing a perfect platform for growth of digital pathology. The technology is anticipated to gain considerably from approval of latest digital pathology platforms and tools by the US FDA. Digital pathology is slated to hold a prominent role in cancer care specialties, especially prostate, skin and breast. The technology is finding increasing acceptance across leading healthcare facilities for analysis of patient images and delivery of enhanced pathology services. Digital pathology significantly improves laboratory efficiency, image management, clinical workflows, diagnostic accuracy and revenues. The technology is likely to gain further from increasing integration with AI and other emerging platforms intended to help pathologists in efficiently dealing with large data volumes for faster and accurate diagnostics. The ability of digital pathology systems to enhance operational efficiency, provide novel treatment methods, reduce lab expenses and more importantly improve overall patient care continues to fuel their adoption worldwide. Digital pathology systems also provide accurate pathological assessment, thus enabling proper, timely and cost effective treatment. The growing need for real time access to pathology outcomes constitutes a major driving force for the digital pathology market.

Also, scarcity of skilled pathologists and excess workloads on pathology teams in research labs and hospital setups continue to drive demand for sophisticated pathology systems. Rising preference for computer-aided diagnosis that enables efficient detection of diseases, quantification of risk assessment and disease progression, and evaluation of results at anatomic level is expected to drive demand for digital pathology systems. Rapidly increasing prevalence of various chronic diseases, such as cancer and cardiac diseases, due to an aging population and changing lifestyles are enhancing the need for faster and more reliable testing and diagnosis systems. In particular, the increasing incidence of cancer across the world and the subsequent increase in demand for timely cancer diagnosis and monitoring solutions remains a prime growth factor for the digital pathology systems market. Digital pathology systems have been proven to increase detection rates of cancer in early stages through identification of indicators that may otherwise go undetected through conventional pathology procedures. Also driving growth are factors such as rising awareness about diagnostic technologies and steadily growing disposable incomes of people across developed and developing economies, which will foster demand for digital pathology systems.

By Type, Human Pathology Segment to Reach $1.1 Billion by 2026


Global market for Human Pathology (Type) segment is estimated at US$474.2 Million in 2020, and is projected to reach US$1.1 Billion by 2026 reflecting a compounded annual growth rate of 14.5% over the analysis period. The United States constitutes the largest regional market for Human Pathology segment, accounting for 41.6% of the global sales in 2020. United States is poised to register the fastest compounded annual growth rate of 16.2% over the analysis period, to reach US$565.8 Million by the end of the analysis period.

Select Competitors (Total 74 Featured) -

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • Carl Zeiss AG
  • Corista LLC
  • Glencoe Software, Inc
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology, Inc.
  • Indica Labs
  • Inspirata Inc
  • KANTERON SYSTEMS S.L.U
  • KONFOONG BIOTECH INTERNATIONAL CO.,LTD
  • Leica Biosystems Nussloch GmbH
  • MikroScan Technologies
  • Inc.
  • Objective Pathology Services
  • Olympus Corporation
  • OptraSCAN, Inc
  • Philips Healthcare
  • Proscia Inc
  • Sectra AB
  • Visiopharm A/S
Frequently Asked Questions about the Global Market for Digital Pathology Systems

What is the estimated value of the Global Market for Digital Pathology Systems?

The Global Market for Digital Pathology Systems was estimated to be valued at $573.9 Million in 2020.

What is the growth rate of the Global Market for Digital Pathology Systems?

The growth rate of the Global Market for Digital Pathology Systems is 13.1%, with an estimated value of $1200.0 Million by 2026.

What is the forecasted size of the Global Market for Digital Pathology Systems?

The Global Market for Digital Pathology Systems is estimated to be worth $1200.0 Million by 2026.

Who are the key companies in the Global Market for Digital Pathology Systems?

Key companies in the Global Market for Digital Pathology Systems include 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Carl Zeiss AG, Corista LLC, Glencoe Software, Inc, Hamamatsu Photonics K.K., Huron Digital Pathology, Inc., Indica Labs and KANTERON SYSTEMS S.L.U.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3DHISTECH Ltd.
  • Corista LLC
  • Hamamatsu Photonics K.K.
  • Indica Labs
  • KANTERON SYSTEMS S.L.U
  • Olympus Corporation

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • COVID-19 Ushers in 2020 as the Year of Healthcare Digitalization
  • Global Venture Capital Investments in Digital Health Startups (In US$ Billion)
  • % Share VC Investments by Category for 2020
  • FDA Temporarily Relaxes Guidelines to Promote Remote Digital Pathology Services amid COVID-19 Pandemic
  • COVID-19 Highlights Need to Implement Structured Online Curriculum for Pathology Training
  • Future Outlook of Pathology Post-COVID-19
  • Digital Pathology Systems - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Digital Pathology: An Introduction
  • Key Digital Pathology Tools
  • Market Outlook
  • US and Europe Maintain Dominance
  • Emerging Markets to Experience Strong Growth
  • Scanners Lead Digital Pathology Market
  • Software Segment Post Strong Growth
  • Disease Diagnosis: Major Application of Digital Pathology Systems
  • Telepathology Experiences Strong Growth
  • Pharmaceutical and Biotechnology Companies: Important End Use Markets for Digital Pathology
  • Global Digital Pathology Systems Market by End-Use: 2020
  • Major Issues Hampering Adoption of Digital Pathology Systems
  • Competitive Landscape
  • Market Share of Leading Players in Digital Pathology Systems Market: 2020E
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Technological Advancements Drive Adoption of Digital Pathology Systems
  • Artificial Intelligence (AI) Steps in to Widen the Scope & Span of Digital Pathology
  • EXIBIT: AI Spending in Healthcare & Lifesciences in US$ Million for Years 2020 & 2025
  • Advantages of AI-Powered Digital Pathology
  • Digital Pathology Benefits Drug Discovery Process
  • Need for Early Diagnosis Puts Focus on Digital Pathology
  • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2018
  • Global New Cancer Cases and Cancer-related Deaths by Cancer Site (in %) for 2018
  • Digital Pathology Emerges as a Tool to Reduce Cases of Cancer Misdiagnoses
  • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
  • Clinical Research Continues to be Core Vertical for Digital Pathology
  • Digital Imaging and Robotic Light Microscopy Boost Growth
  • Computational Pathology for Leading-Edge Image Analytics
  • Cloud Platform Gains Momentum
  • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
  • Rise in Significance of Personalized Medicine Bodes Well for Digital Pathology
  • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019 and 2024
  • Increased Focus on Companion Diagnostics to Benefit Market Growth
  • Improving Healthcare & Research Expenditure to Support Growth
  • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Aging Population: A Key Opportunity Indicator
  • Global Aging Population: Population of 65+ Individuals (in Thousands) by Region for 2019 and 2030
  • Global Population of 65+ Individuals as % of Total Population by Region for 2019 and 2030
  • Global Cancer Deaths by Age Group (in %) for 2019
  • Challenges Facing Digital Pathology Systems Market
  • High Costs
  • Workflow Integration with Other Related Functions
  • Other Issues

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • COVID-19 Triggers Demand for Digital Pathology
  • Market Overview
  • Increasing Pressure on Pathological Labs: Cornerstone for Growth

CANADA

JAPAN

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Market Overview

CHINA

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Market Overview

EUROPE

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Market Overview

FRANCE

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Market Overview

AUSTRALIA

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Market Overview
  • Inadequate Infrastructure Impedes Adoption of Telepathology

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Digital Pathology Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 74
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • Carl Zeiss AG
  • Corista LLC
  • Glencoe Software, Inc
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology, Inc.
  • Indica Labs
  • Inspirata Inc
  • KANTERON SYSTEMS S.L.U
  • KONFOONG BIOTECH INTERNATIONAL CO.,LTD
  • Leica Biosystems Nussloch GmbH
  • MikroScan Technologies
  • Inc.
  • Objective Pathology Services
  • Olympus Corporation
  • OptraSCAN, Inc
  • Philips Healthcare
  • Proscia Inc
  • Sectra AB
  • Visiopharm A/S
Note: Product cover images may vary from those shown